Sign In
Buy ACMSY
$0.130
+0 (+0%)
At Close: Aug 16, 2022
Information
107 Cheapside
London EC2V 6DN
www.accustem.com
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Description
Accustem Sciences Limited engages in the genomic signature-based assay business for the prognosis of early and late recurrence of ER+/HER2 breast cancer in early stage breast cancer patients. The company was incorporated in 2020 and is based in London, the United Kingdom.
